HIGHLIGHTS
- who: Drug-coated balloon and colleagues from the An independent critical event committee consisting of three members from Denmark (ProfJens Lassen, Odense Universitetshospital and University of Southern Denmark), Germany (Dr. Florian Krackhardt, Charitu00e9 Universitu00e4tsmedizin, Berlin) and France (Dr. Georgios Sideris, Georges Pompidou APHP Paris) evaluate all device-event relationships for serious adverse events. Adverse events (AE), including non-serious and serious AEs, are continuously monitored before patient discharge of index PCI and during, weeks, , and , months follow-up. Stopping and Discontinuation Criteria have published the research: STUDY PROTOCOL, in the Journal: (JOURNAL)
- what: The aim . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.